Skip to content
Carteolol
Cartrol, Ocupress (carteolol) is a small molecule pharmaceutical. Carteolol was first approved as Cartrol on 1988-12-28. It is used to treat hypertension and open-angle glaucoma in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
cardiovascular diseasesD002318
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Carteolol hydrochloride
Tradename
Company
Number
Date
Products
CARTROLAbbVieN-019204 DISCN1988-12-28
3 products
OCUPRESSNovartisN-019972 DISCN1990-05-23
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
carteolol hydrochlorideANDA2012-03-07
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
hypertensionEFO_0000537D006973I10
open-angle glaucomaEFO_0004190D005902H40.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
— C07: Beta-adrenergic blocking agents
— C07A: Beta blocking agents
— C07AA: Beta blocking agents, non-selective
— C07AA15: Carteolol
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01E: Antiglaucoma preparations and miotics
— S01ED: Beta blocking agents, antiglaucoma preparations and miotics
— S01ED05: Carteolol
— S01ED55: Carteolol, combinations
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCARTEOLOL
INNcarteolol
Description
Carteolol is a quinolone and a secondary alcohol. It has a role as a beta-adrenergic antagonist, an antihypertensive agent, an antiglaucoma drug, an anti-arrhythmia drug and a sympatholytic agent. It is a conjugate base of a carteolol(1+).
Classification
Small molecule
Drug classbeta-blockers (propranolol type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2
Identifiers
PDB—
CAS-ID51781-06-7
RxCUI2116
ChEMBL IDCHEMBL839
ChEBI ID3437
PubChem CID2583
DrugBankDB00521
UNII ID8NF31401XG (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 686 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details